A211130
同義詞:
DMT-2′-O-甲基-rA(bz)酰胺, N-苯甲酰-5′-O- [双(4-甲氧苯基)苯甲基]-2′-O-甲基-腺苷,3′-[2-氰乙基 N,N-双(1-甲基乙基)亚磷酰胺]
1 of 10
Sigma-Aldrich
A211150
DMT-2′O-Methyl-rA(bz) 磷酰胺
A211100
G211140
DMT-2′O-Methyl-rG(ib) Phosphoramidite
U211130
DMT-2′O-Methyl-rU Phosphoramidite
C213140
DMT-2′O-Methyl-rC(ac) Phosphoramidite
Avanti
860677P
C18神经酰胺-d7(d18:1-d7/18:0)
A211140
A211250
DMT-2′Fluoro-dA(bz) Phosphoramidite
772135
Phenyl 1-thio-β-D-galactopyranoside
860516P
C16神经酰胺(d18:1/16:0)
non-animal source (no BSE/TSE risk)
Proligo Reagents
≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
powder
oligo synthesis: suitable
≤0.1% single unspecified Impurity (reversed phase HPLC)≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3% residual Solvent content
white to off-white
conforms (UV/VIS Identity)
conforms to structure for H-NMRconforms to structure for LC-MS
configured for ABI
base: adenosinebase protecting group: benzoyl2' protecting group: methyl5' protecting group: DMTdeprotection: standard
2-8°C
CO[C@@H]1[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(c2ccccc2)(c3ccc(OC)cc3)c4ccc(OC)cc4)O[C@H]1n5cnc6c(NC(=O)c7ccccc7)ncnc56
1S/C48H54N7O8P/c1-32(2)55(33(3)4)64(61-28-14-27-49)63-42-40(62-47(43(42)59-7)54-31-52-41-44(50-30-51-45(41)54)53-46(56)34-15-10-8-11-16-34)29-60-48(35-17-12-9-13-18-35,36-19-23-38(57-5)24-20-36)37-21-25-39(58-6)26-22-37/h8-13,15-26,30-33,40,42-43,47H,14,28-29H2,1-7H3,(H,50,51,53,56)/t40-,42-,43-,47-,64?/m1/s1
AZCGOTUYEPXHMJ-PSVHYZMASA-N
尋找類似的產品? 前往 產品比較指南
11 - Combustible Solids
WGK 3
Not applicable
從最近期的版本中選擇一個:
未看到正確版本?
如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。
您可以在文件庫中找到最近購買的產品相關文件。
存取文件庫
1 of 2
Supelco
52738-U
Supelclean™ PSA 固相萃取散装填料
MP0030
LookOut® 支原体消除试剂盒
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.